Sign in

CIK 0001335105

  • Non-accelerated filer
  • Smaller reporting company

NOMAD POWER SOLUTIONS, INC.

Sign in to watch
Ticker
NMAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202903526
Phone
+1 310-203-2902
Business address
433 PLAZA REAL, SUITE 275, BOCA RATON, FL, 33432
Former names
LIXTE BIOTECHNOLOGY HOLDINGS, INC., SRKP 7 INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 3 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-09 Pursglove Geordan Garrett Resigned as CEO & Chairman Grant or award +1,500,000 2,122,687
2026-07-01 Stazzone Peter Chief Financial Officer Grant or award +50,000 100,000
2026-07-01 Sawyer Jason David Director Grant or award +40,000 65,000
2026-07-01 Pursglove Geordan Garrett CEO and Chairman of the Board Grant or award +350,000 700,000
2026-07-01 Primus Guy Warren Director Grant or award +15,000 40,000
2026-07-01 Holloway Michael Andrew Director Grant or award +15,000 40,000
2026-07-01 Felix Lourdes Director Grant or award +30,000 55,000
2026-05-29 Porter Stuart D Director Grant or award +25,000 25,000
2026-04-15 Stazzone Peter Chief Financial Officer Grant or award +50,000 50,000
2026-04-15 Stazzone Peter Chief Financial Officer Returned to the company · Options to Purchase Common Stock −50,000 0
2026-04-15 Sawyer Jason David Director Grant or award +25,000 25,000
2026-04-15 Sawyer Jason David Director Returned to the company · Options to Purchase Common Stock −25,000 0
2026-04-15 Pursglove Geordan Garrett CEO and Chairman of the Board Grant or award +350,000 350,000
2026-04-15 Pursglove Geordan Garrett CEO and Chairman of the Board Returned to the company · Options to Purchase Common Stock −350,000 0
2026-04-15 Primus Guy Warren Director Grant or award +25,000 25,000
2026-04-15 Primus Guy Warren Director Returned to the company · Stock Option (right to buy) −25,000 0
2026-04-15 Holloway Michael Andrew Director Grant or award +25,000 25,000
2026-04-15 Holloway Michael Andrew Director Returned to the company · Options to Purchase Common Stock −25,000 0
2026-04-15 Felix Lourdes Director Grant or award +25,000 25,000
2026-04-15 Felix Lourdes Director Returned to the company · Stock Option (right to buy) −25,000 0

Page 1 of 8 · 145 trades